Email alerts

Subscribe to our mailing list


Since Tri-Solfen® was commercially launched, over 150 million lambs have been treated and over 80% of Australian wool growers are now using Tri-Solfen for their sheep. Here’s what some of them have to say…

‘We have used pain relief for two years now and seen real production gains. We are concerned for the welfare of our animals and will continue to use pain relief to ensure they get the best care.’

Clinton Wise– Wililoo Merino Stud, Woodanilling, W.A.

'It easy to see the difference pain relief makes. Before, lambs would walk away hunched up, even taking a couple of hours to walk back to the paddock. Now they run straight back to Mum and start suckling,” says Rod. “My wool is now sold under the Better Choices brand. I see this as a definite advantage. I think it will be an advantage in the long run, to both me and the industry as a whole.'

Rod Miller– Glenpaen Merino Stud, Horsham, Vic

'After being treated with pain relief my lambs were more content and less stressed. As farmers we are sincere in looking after the welfare of our animals and using pain relief demonstrates this.'

Richard Coole– Frankland, W.A.

'We have been using pain relief for the past three years. We’re impressed by reduced bleeding in the mulesing wound immediately after application. Lambs run straight back to find the ewe, which has dramatically reduced our mortality rates. Flock management, post lamb marking is easier due to the effect of pain relief and the scab healing faster.'

Ryan & Malcom O’Dea– Peepingee Merino Stud, Narrogin, W.A.

'Using pain relief eases the stress and allows lambs to mother up and move back to the paddock easier with faster weight gains.'

Kent Lummis– Waverley Downs, Gilgandra, NSW


Patent Portfolio

Country Species Patent
Australia Sheep Granted
Australia Horses, Dogs, Lab animals Granted
Australia Cattle Granted
Australia Humans Granted
Horses, Dogs, Lab animals Granted
EU Humans Granted
EU Pig, Sheep,
USA Dogs, Horses, Lab animals Granted
USA Humans Granted
USA Pig, Sheep,
Canada Horses, Dogs, Lab animals Granted
Canada Cattle,
Canada Humans Granted


Advisory Board

Ian Page

Non-Executive Director

Ian is Chief Executive Officer of Dechra Pharmaceuticals, which has a 33% shareholder in Medical Ethics. He joined National Veterinary Services, Dechra’s former services business in 1989 and joined the Board of Dechra in 1997. In October 2010, Ian was appointed as Non-Executive Chairman of Sanford DeLand Asset Management.

Dr Chris Roberts

Human Wound and Regulatory Advisor

Chris has over 20 years’ line management experience of heading clinical research teams. He was previously global head of Smith & Nephew clinical support and market development, where he managed global clinical Phase II and III programmes in the management of venous and pressure ulcers.

Lieutenant Colonel Professor Steven Jeffery

Medical Specialist Advisor

Steve has over 15 years’ experience in military plastic surgery. In 2011 he was awarded the Military Civilian Partnership Award for ‘Regular of the Year’, as well as receiving the Wounds UK ‘Key Contribution’ award and the Smith and Nephew ‘Customer Pioneer of the Year’ award. He has also been awarded Fellowship of the Royal College of Surgeons of England ad eundum. He is an expert adviser to NICE Medical Technologies Evaluation Programme. Steve co-founded the Woundcare 4 Heroes charity, which is already making a big difference to the wound care of both serving and veteran personnel.

Dr Matthew Bayfield

Medical Specialist Scientific Director

Dr Matthew Bayfield, Head of Cardiothoracic Surgery, Strathfield Private Hospital and VMO Cardiothoracic Surgeon, Royal Prince Alfred Hospital.

Professor Peter Windsor

Veterinarian Research Advisor

Peter is a registered specialist veterinary surgeon in New South Wales and an emeritus Professor at Sydney University. He holds a BVSc (Hons), PhD, DVSc and diploma from the European College of Small Ruminant Health Management.

Dr Julian Braidwood

Global Regulatory Affairs Advisor

Julian has held leadership roles and managed international clinical projects with Grampian. He was previously Regulatory Affairs Manager at Novartis Animal Health. He is the Founder and Managing Director of Triveritas, where he is responsible for a team of 40 animal health specialists across the EU and the US.


Press Release

Animal welfare and good business go hand in hand

April 25, 2019

Medical Ethics and Winterbotham Darby raising awareness for better animal welfare in the food industry

Melbourne, Australia – 25 April 2019 – Medical Ethics Pty Ltd (“Medical Ethics” or “the Group”), a commercial and development company focused on pain mitigation in wounds for humans and animals, announces that it has partnered with Winterbotham Darby, a market leader in the innovation and supply of continental meats, to raise awareness to ensure better animal care standards in the food industry and show that animal welfare can go hand in hand with good business.

This year’s Animal Health and Welfare Day, hosted between Winterbotham Darby and the University of Bristol’s School of Veterinary Sciences, was dedicated to sharing methods, technology and programmes that are at the forefront of animal welfare in the supply and manufacturing of food. The event showcased a variety of collaborations between academia and industry, attracting attendance from businesses, charities, major retailers and production partners. Presentations during the fourth annual event demonstrated the pressing need to improve the welfare of commercial livestock and highlighted the dedication and passion within the industry towards enhancing animal health.

Recognised by leading veterinarians and animal welfare scientists, Medical Ethics was recognised as the first and only company to develop a safe and cost-effective solution for animals to overcome the pain associated with surgical procedures, a key priority in improving animal welfare. Tri-Solfen®, Medical Ethics’ innovative spray and stay topical local anaesthetic and antiseptic gel, is designed to adhere to wounds to provide rapid onset numbing with prolonged analgesia effects. It also contains active ingredients designed to minimise bleeding, protect against infection, coat the wound and promote healing.

In collaboration Medical Ethics and Winterbotham Darby have created the following video about the potential global role of Tri-Solfen® in improving animal care –

Allan Giffard, Managing Director of Medical Ethics, commented:
“It is great to hear that Tri-Solfen® is recognised by key industry leaders, such as Winterbotham Darby, as an important component in an ethical farming industry. It reinforces our belief in Tri-Solfen® as a practical pain management solution, for accidental wounds and those created by surgery, in livestock and companion animals. The product has already been used with over 100 million animals across New Zealand and Australia, and we strongly believe it has the potential to fill a large unmet need in all global markets.”

Susie White, Communications Manager of Winterbotham Darby, added:
“By taking the approach to unite the whole supply chain, from farmer and producer to customer, we have made significant progress in improving farm animal welfare across Europe. Treating animals in the best way that we can is of upmost importance to us, and this involves reducing pain during necessary surgical procedures whenever possible. As the ethical production and manufacturing of food is high on the public and personal agenda, any product that helps with improving animal care, such as Tri-Solfen®, should be considered for use when raising livestock.”

Further information

Medical Ethics:

Allan Giffard, Managing Director
Charles Olsson, Marketing Director
+61 419 362 286

FTI Consulting:

Brett Pollard, Victoria Foster Mitchell
+44 (0)20 3727 1000